← Mechanisms of action
IFNB1
SINGLE PROTEINHomo sapiens
Preferred name: Interferon beta ChEMBL ↗
Linked proteins
Drugs acting on this target (9)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| pf-06823859 | Inhibitor | experimental | mAb | IFNB1 inhibitor |
| pf-07264660 | Inhibitor | experimental | Small molecule | inhibitor - IFNB1 |
| ad.hifn-beta | Supplementation | experimental | Gene therapy | supplementation - ifnb1 |
| interferon beta-1a (Avonex) | Supplementation | approved | Recombinant protein | IFNB1 supplementation |
| interferon beta-1b (betaseron) | Supplementation | approved | Recombinant protein | IFNB1 supplementation |
| peginterferon beta-1a (Plegridy) | Supplementation | approved | Recombinant protein | IFNB1 supplementation |
| recombinant adenovirus-hifn-beta | Supplementation | experimental | Biological | IFNB1 supplementation |
| recombinant vesicular stomatitis virus-expressing human interferon beta and sodium-iodide symporter | Supplementation | experimental | Gene therapy | IFNB1 supplementation |
| recombinant vesicular stomatitis virus-expressing interferon-beta | Supplementation | experimental | Vaccine | IFNB1 supplementation |